403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Nagarro Appoints Prateek Aggarwal As Chief Financial Officer And Member Of The Management Board
|
Nagarro SE
/ Key word(s): Personnel
Nagarro appoints Prateek Aggarwal as Chief Financial Officer and member of the Management Board 16.04.2026 / 15:13 CET/CEST The issuer is solely responsible for the content of this announcement. Appointment is an important step in strengthening Nagarro's finance leadership and governance
About Nagarro Nagarro, a global digital engineering leader, helps clients become fluidic, innovative, digital-first companies and thus win in their markets. The company is distinguished by its entrepreneurial, agile, and global character, its CARING mindset, and its Fluidic Intelligence vision. Nagarro employs around 17,700 people in 39 countries. For more information, visit . FRA: NA9 (SDAX/TecDAX, ISIN DE000A3H2200, WKN A3H220) For inquiries, please contact .... 16.04.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. The issuer is solely responsible for the content of this announcement. The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | Nagarro SE |
| Baierbrunner Straße 15 | |
| 81379 München | |
| Germany | |
| Phone: | 089 / 785 000 282 |
| E-mail: | ... |
| Internet: | |
| ISIN: | DE000A3H2200 |
| WKN: | A3H220 |
| Indices: | TecDAX, SDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate BSX |
| EQS News ID: | 2309916 |
2309916 16.04.2026 CET/CEST |
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment